Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.

Type 2 diabetes is no longer a lifelong sentence; emerging research shows it can be reversed With strategic lifestyle changes ...

Kolkata: Prices of 42 medicines, including those used for day-to-day consumption, are likely to change following an order by ...

SGLT-2 inhibitors canagliflozin, empagliflozin, and dapagliflozin showed overall comparable effectiveness on cardiovascular outcomes in T2D.

Experts are now calling for NHS guidance - which does not recommend managing diabetes with different drugs depending on age - ...